ppt chapter 20-1
DESCRIPTION
TRANSCRIPT
![Page 1: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/1.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Anxiolytic and Hypnotic AgentsAnxiolytic and Hypnotic Agents
Chapter 20
![Page 2: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/2.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Types of Anxiolytic and Hypnotic AgentsTypes of Anxiolytic and Hypnotic Agents
• Anxiolytics
– Prevent feelings of tension or fear
• Sedatives
– Calm and make patients unaware of the environment
• Hypnotics
– Cause sleep
• Minor Tranquilizers
– Produce a state of tranquility in anxious patients
![Page 3: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/3.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Psychological States Affected by Anxiolytic and Hypnotic Drugs
Psychological States Affected by Anxiolytic and Hypnotic Drugs
• Anxiety
– Feeling of tension, nervousness, apprehension, or fear involving unpleasant reactions to a stimulus
• Sedation
– Loss of awareness and reaction to environmental stimuli
• Hypnosis
– Extreme sedation resulting in further CNS depression and sleep
![Page 4: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/4.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Sites of Action of Benzodiazepines and Barbiturates and Other Anxiolytics
Sites of Action of Benzodiazepines and Barbiturates and Other Anxiolytics
![Page 5: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/5.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Benzodiazepine: ActionBenzodiazepine: Action
• Act in the limbic system and the RAS
• Make GABA more effective
• Causes interference with neurons firing
• Lower doses cause anxiolytic effects
• Higher doses cause sedation and hypnosis
![Page 6: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/6.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Benzodiazepine: IndicationsBenzodiazepine: Indications
• Anxiety disorders
• Alcohol withdrawal
• Hyperexcitability and agitation
• Preoperative relief of anxiety and tension
![Page 7: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/7.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Benzodiazepine: PharmacokineticsBenzodiazepine: Pharmacokinetics
• Well absorbed from GI tract
• Peak levels achieved in 30 minutes to 2 hours
• Lipid soluble and distributes well throughout the body
• Cross placenta
• Enter breast milk
• Metabolized in the liver
• Excretion is primarily in the urine
![Page 8: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/8.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Benzodiazepine: Contraindications and Cautions
Benzodiazepine: Contraindications and Cautions
• Allergy to benzodiazepine
• Psychosis
• Acute narrow angle glaucoma
• Shock
• Coma
• Acute alcohol intoxication
• Pregnancy
![Page 9: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/9.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Benzodiazepine: Adverse EffectsBenzodiazepine: Adverse Effects
• Sedation
• Drowsiness
• Depression
• Lethargy
• Blurred Vision
• Confusion
• Dry Mouth
• Constipation
• Nausea
• Vomiting
• Hypotension
• Urinary Retention
![Page 10: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/10.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Benzodiazepine: Drug-to-Drug Interactions
Benzodiazepine: Drug-to-Drug Interactions
• Increase CNS depression when taken with alcohol
• Increase in effect when taken with cimetidine, oral contraceptives, or disulfiram
• Decrease in effect if given with theophylline or ranitidine
![Page 11: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/11.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
A client presents at the clinic with symptoms of hyperexcitability and agitation. Which medication would the nurse expect the physician to prescribe?
A. Hypnotic
B. Benzodiazepine
C. Barbiturate
D. Other Anxiolytic and Hypnotic Drugs
![Page 12: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/12.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
B. Benzodiazepine
Rationale: Hyperexcitability and agitation are indications for the use of benzodiazepines.
![Page 13: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/13.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
BarbituratesBarbiturates
• Act as a general CNS depressant
• Inhibit neuronal impulse conduction in the ascending RAS
• Depress the cerebral cortex
• Alter cerebellar function
• Depress motor output
![Page 14: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/14.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Barbiturates: ActionBarbiturates: Action
• CNS depressants
• Inhibit neuroral impulse conduction in the ascending RAS
• Depress cerebral cortex
• Depress motor output
• Cause: sedation, hypnosis, anesthesia, and coma
![Page 15: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/15.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Barbiturates: IndicationBarbiturates: Indication
• Relief of the signs and symptoms of anxiety
• Sedation
• Insomnia
• Preanesthesia
• Seizures
![Page 16: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/16.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Barbiturates: Pharmacokinetics Barbiturates: Pharmacokinetics
• Well absorbed
• Reaching peak in 20 – 60 minutes
• Metabolized in the liver
• Excreted in the urine
![Page 17: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/17.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Barbiturates: Contraindications and Cautions
Barbiturates: Contraindications and Cautions
• Allergy to any barbiturate
• Previous history of addiction to sedative–hypnotic drugs
• Latent or manifest porphyria
• Marked hepatic impairment or nephritis
• Respiratory distress or severe respiratory dysfunction
• Pregnancy
![Page 18: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/18.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Barbiturates: Adverse ReactionsBarbiturates: Adverse Reactions
• CNS Depression
• Physical Dependency
• Drowsiness
• Somnolence
• Lethargy
• Ataxia
• Vertigo
• Nausea
• Vomiting
• Constipation
![Page 19: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/19.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Barbiturates: Drug-to-Drug InteractionsBarbiturates: Drug-to-Drug Interactions
• Increase CNS depression when given with alcohol, antihistamines, and other tranquilizers
• Altered response to phenytoin
• MAO cause increase serum levels and effect
• Decrease effectiveness of the following drugs: anticoagulants, digoxin, tricyclic antidepressants, corticosteroids, oral contraceptive
![Page 20: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/20.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
Please answer the following statement as true or false.
Peak levels of barbiturates occur in 60 to 90 minutes.
![Page 21: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/21.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
False
Rationale: The barbiturates are absorbed well, reaching peak levels in 20 to 60 minutes.
![Page 22: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/22.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Other Anxiolytic and Hypnotic DrugsOther Anxiolytic and Hypnotic Drugs
• Paraldehyde (Paral): Sedates patients with delirium tremens or psychiatric conditions characterized by extreme excitement
• Meprobamate (Miltown): Manages acute anxiety for up to 4 months
• Chloral Hydrate (Aquachloral): Produces nocturnal sedation or preoperative sedation
![Page 23: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/23.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Other Anxiolytic and Hypnotic Drugs (cont.)
Other Anxiolytic and Hypnotic Drugs (cont.)
• Glutethimide (generic), zaleplon (Sonata), and zolpidem (Ambien): Short-term treatment of insomnia
• Antihistamines (promethazine [Phenergan], diphenhydramine [Benadryl]): Preoperative medications and postoperative to decrease the need for narcotics
• Buspirone (BuSpar): Reduces the signs and symptoms of anxiety without severe CNS and adverse effects
![Page 24: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/24.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Use of Anxiolytic and Hypnotic Agents Across the Life Span
Use of Anxiolytic and Hypnotic Agents Across the Life Span
![Page 25: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/25.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Benzodiazepines AgentPrototype Benzodiazepines Agent
![Page 26: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/26.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Barbiturates AgentPrototype Barbiturates Agent
![Page 27: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/27.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Prototype Barbiturates Agent (Continued)Prototype Barbiturates Agent (Continued)
![Page 28: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/28.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Benzodiazepines
Nursing Considerations for Benzodiazepines
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
![Page 29: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/29.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
Nursing Considerations for Barbiturates Nursing Considerations for Barbiturates
• Assessment: History and Physical Exam
• Nursing Diagnosis
• Implementation
• Evaluation
![Page 30: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/30.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
QuestionQuestion
You are admitting a new patient to the clinic. A review of home medications indicates the patient is taking a barbiturate to help him sleep. The patient tells you that he is having problems with both his visual and auditory senses. The patient wants to know what is wrong. What would be the best response?
A. We will have to wait and see what the doctor says.
B. What you are describing could be adverse effects from the sleep medicine you are taking.
C. There is nothing wrong. You are just getting older.
D. Sometimes these things happen with our patients. We need to do a complete assessment before we know for sure.
![Page 31: Ppt chapter 20-1](https://reader030.vdocuments.mx/reader030/viewer/2022020715/549297ceb47959794d8b464d/html5/thumbnails/31.jpg)
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins
AnswerAnswer
B. What you are describing could be adverse effects from the sleeping medication you are taking?
Rationale: Nursing diagnoses related to drug therapy might include: Disturbed thought processes and disturbed sensory perception (visual, auditory, kinesthetic, tactile) related to CNS effects